Dana Hoffmann
Impact in
- Nephrology top 2%
- Acute Kidney Injury Research
- Chronic Kidney Disease and Diabetes
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Chronic Kidney Disease and Diabetes 8
- Acute Kidney Injury Research 3
-
- Renal and related cancers 3
- Co-authors
- Angela Mally (8 shared papers)W. Dekant (6 shared papers)Vishal S. Vaidya (8 shared papers)Eva Rached (3 shared papers)Philip Hewitt (4 shared papers)Katja Matheis (5 shared papers)Victoria Ramírez (3 shared papers)Sushrut S. Waikar (3 shared papers)
- Journals
- Toxicological Sciences (4 papers)Toxicology Letters (2 papers)American Journal of Physiology-Renal Physiology (2 papers)Toxicology and Applied Pharmacology (2 papers)Acta Anaesthesiologica Scandinavica (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Dana Hoffmann
19 papers receiving 900 citations
Peers
Comparison fields: 5 of 102
- Nephrology 314
- Pharmacology 96
- Cancer Research 151
- Transplantation 18
- Critical Care and Intensive Care Medicine 32
Countries citing papers authored by Dana Hoffmann
This map shows the geographic impact of Dana Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Hoffmann more than expected).
Fields of papers citing papers by Dana Hoffmann
This network shows the impact of papers produced by Dana Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Hoffmann. The network helps show where Dana Hoffmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Dana Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 160 | |
| 2 | 2010 | 147 | |
| 3 | 2008 | 108 | |
| 4 | 2009 | 108 | |
| 5 | 2010 | 85 | |
| 6 | 2011 | 46 | |
| 7 | 2012 | 37 | |
| 8 | 2014 | 36 | |
| 9 | 2007 | 33 | |
| 10 | 2010 | 26 | |
| 11 | 2013 | 26 | |
| 12 | 2011 | 24 | |
| 13 | 2010 | 22 | |
| 14 | 2013 | 22 | |
| 15 | 2022 | 13 | |
| 16 | 2022 | 12 | |
| 17 | 1975 | 11 | |
| 18 | Improved therapeutic index of cisplatin analogue: B-85-0040 by circadian timing. | 1990 | 1 |
| 19 | Anomalies of the external urethral orifice in girls. | 1984 | 1 |
| 20 | 2009 | 0 |
About Dana Hoffmann
Dana Hoffmann is a scholar working on Nephrology, Molecular Biology, Surgery, Health, Toxicology and Mutagenesis and Oncology, having authored 20 papers that have together received 918 indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (8 papers), Renal and related cancers (3 papers), Acute Kidney Injury Research (3 papers), Clusterin in disease pathology (3 papers), Heavy Metal Exposure and Toxicity (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Biomarkers in Disease Mechanisms (2 papers) and Neural dynamics and brain function (1 paper). The work is most often cited by research in Nephrology (314 citations), Pharmacology (96 citations), Cancer Research (151 citations), Transplantation (18 citations) and Critical Care and Intensive Care Medicine (32 citations). Dana Hoffmann has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Angela Mally, W. Dekant, Vishal S. Vaidya, Eva Rached, Philip Hewitt, Katja Matheis, Victoria Ramírez, Sushrut S. Waikar, Vanesa Bijol and Ronald P. Brown. Their work appears in journals such as Toxicological Sciences, Toxicology Letters, American Journal of Physiology-Renal Physiology, Toxicology and Applied Pharmacology and Acta Anaesthesiologica Scandinavica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.